-
Sort By
-
Newest
-
Newest
-
Oldest
-
All Categories
-
All Categories
-
Alternatives
-
ASX
-
Crypto
-
ESG
-
ETFs
-
Global
-
Growth
-
IPO
-
M&A
-
Small caps
-
Unlisted Assets
-
Value
Risk on, gold down, more clarity on Victoria’s state of disaster The ASX 200 (ASX:XJO) followed a global lead higher, adding close to 200 points to finish up 1.9% for the day. Every sector was positive, with IT and energy particular standouts adding 3.2% and 2.6% respectively, following better than expected manufacturing data in the…
The ASX 200 (XJO:ASX) fell 2.0% on Friday, but managed to hold onto a 0.5% gain for the month; it’s fourth straight winning month.
Treasurer Frydenberg provided his long-awaited budget update, which was just that an update, offering little in the way of guidance into the future. The Government are predicting unemployment will peak at 9.25% across the country, with ballooning deficits adding $250 billion to the debt pile.
The ASX 200 (ASX:XJO) finished off its lows for the day, falling 1.3%, as both Victoria and several US states hit record COVID-19 case levels, denting market sentiment.
Despite an increasing chorus of experts suggesting the technology sector has moved beyond reasonable levels, the rally continues. The ASX 200 (ASX:XJO) added 2.6%, hitting a six week high, with a 5.7% rally in the IT sector among the largest contributors.
The ASX 200 (ASX:XJO) continued its recent weakness, falling 0.5% on Monday, as concerns of a secondary outbreak in NSW and escalating deaths in the US hit investor confidence.
Sideways….a weak opening ahead It was another bumpy, albeit positive, week for markets with the ASX 200 (ASX:XJO) gaining 0.4% on Friday and finishing around 2.0% higher for the week. The primary driver remained Australia’s main recovery hope, commodity exports, with the materials sector finishing 4.2% as the iron ore price remained above USD$115 per…
The ‘Vaccine’ rally was short-lived with a swathe of economic data sending the ASX 200 (ASX:XJO) 0.7% lower on Thursday.
The ASX 200 joined the global sharemarket rally, adding 1.9%, after healthcare US biotech company Moderna Inc. (NASDAQ:MRNA) announced positive results from their Phase 1 trial of a potential COVID-19 treatment.
Six blue-chip updates In the middle of another COVID-19 shutdown and with most companies approaching full-year earnings season, it’s important to take stock of what occurred in the previous few months. We’ve decided to provide an update on some non-traditional Aussie blue-chips after the strongest quarterly performance for the market in decades. Macquarie Group (ASX:MQG)…
The ASX 200 (ASX:XJO) experienced another choppy day, with intra-day likely to be the new normal, finishing 0.6% lower. Consumer staples (+0.2%) offered the only protection as the impacts of Victoria’s widespread shutdowns and a reversal of recently eased restrictions in the US were front and centre once again.
The ASX 200 (ASX:XJO) gained another 1%, taking a positive lead from US markets, with over 60% of the rally coming from the Big Four Banks, Commonwealth Bank of Australia Ltd (ASX:CBA) up 2.2%, and miners, BHP Group Ltd (ASX:BHP) up 2.2% after the iron ore price exceeding US$118 per tonne.